Q1 2026 Management view Exponent reported Q1 growth tied to AI-related client work and a mix shift across proactive and reactive engagements. Dr. Catherine Corrigan (President, CEO & Director) said, ...
StockStory.org on MSN
Exponent (NASDAQ:EXPO) beats expectations in strong Q1 CY2026
Scientific consulting firm Exponent (NASDAQ:EXPO) announced in Q1 CY2026, with sales up 21% year on year to $166.3 million.
Exponent is a market leader in scientific and engineering consulting, boasting a 13-year dividend growth streak. Check out ...
Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2026 ended April 3, 2026. "Exponent delivered ...
Sold 344,631 shares of Exponent, representing an estimated $24.63 million based on the average price for the third quarter ended September 30, 2025 After the sale, the fund holds 2,361,196 shares ...
Exponent (NASDAQ:EXPO) reported double-digit growth in first-quarter fiscal 2026 net revenues and earnings, pointing to ...
MENLO PARK, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (EXPO) today reported financial results for the fourth quarter and fiscal year 2025 ended January 2, 2026. “We delivered a strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results